Category: digital health

Most active health system AI investors

Rochester, Minn.-based Mayo Clinic leads the way in artificial intelligence investments among health systems, according to a July 15 report from CB Insights. 

What are health systems' top digital priorities?

Health systems are prioritizing their digital spending on artificial intelligence scribes and other AI technology.

Digital health funding finding momentum

Digital health funding is seeing a rebound with startups raising $5.7 billion across 266 deals in the first half of 2024, according to a July 8 report from Rock Health. 

Why 2 health systems created a virtual care startup

Two health systems were a “match made in heaven” when they collaborated to form a virtual care company that has already been a hit with patients.

10 most exciting digital health startups

Abridge, a company founded in 2018 that uses AI to automate medical records based on conversations between clinicians and patients, was named the No.1 most exciting digital health startup in a June 25 report by TechCrunch.

Digital health company stands by leaders accused of fraud

Done Global, which supplies stimulant medications to thousands of patients, said it disagrees with the fraud charges filed against its CEO and clinical president. 

Health system CIO joins AI startup

A former health system CIO recently joined a healthcare artificial intelligence startup.

Why patients aren't using virtual care

Nearly half of patients have had a virtual health appointment in the past two years, and 9 in 10 of those individuals were satisfied with the visit, according to a report from healthcare communications firm Jarrard Inc.

Providence's digital health spinoff lands 3 big health system investors

Three large health systems became strategic investors in DexCare, a digital health spinoff from Renton, Wash.-based Providence’s Digital Innovation Group.

Digital health executives' arrests could disrupt ADHD treatment, CDC says

The CDC issued an alert that the recent arrests of two digital health company executives on fraud charges could disrupt treatment for individuals with attention-deficit hyperactivity disorder.